X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11959) 11959
Book Review (2268) 2268
Newsletter (893) 893
Publication (685) 685
Book Chapter (82) 82
Newspaper Article (64) 64
Conference Proceeding (47) 47
Transcript (20) 20
Dissertation (14) 14
Magazine Article (13) 13
Book / eBook (5) 5
Report (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10245) 10245
humans (7900) 7900
thrombin (7043) 7043
male (4400) 4400
animals (4015) 4015
female (3216) 3216
hematology (2949) 2949
peripheral vascular disease (2308) 2308
middle aged (2109) 2109
anticoagulants (1975) 1975
aged (1785) 1785
adult (1701) 1701
analysis (1367) 1367
coagulation (1316) 1316
blood coagulation - drug effects (1299) 1299
pharmacology & pharmacy (1289) 1289
abridged index medicus (1284) 1284
rats (1279) 1279
prothrombin (1249) 1249
surgery (1222) 1222
thrombosis (1196) 1196
blood (1165) 1165
anticoagulants - therapeutic use (1120) 1120
thrombin - metabolism (1096) 1096
cardiac & cardiovascular systems (1088) 1088
warfarin (1076) 1076
anticoagulants - administration & dosage (1040) 1040
thrombin - antagonists & inhibitors (997) 997
treatment outcome (997) 997
mice (992) 992
research (992) 992
thrombin - administration & dosage (988) 988
heparin (979) 979
administration, oral (965) 965
dose-response relationship, drug (939) 939
thrombin generation (893) 893
thrombin - pharmacology (862) 862
time factors (856) 856
dabigatran (847) 847
fibrin (798) 798
venous thromboembolism (787) 787
medical examination (769) 769
anticoagulants - pharmacology (765) 765
plasma (764) 764
medicine & public health (744) 744
activation (731) 731
anticoagulants - adverse effects (709) 709
direct thrombin inhibitor (704) 704
care and treatment (696) 696
risk factors (673) 673
thromboembolism (672) 672
health aspects (657) 657
hemostasis (653) 653
inflammation (652) 652
prevention (628) 628
stroke (625) 625
partial thromboplastin time (624) 624
blood coagulation (621) 621
platelets (604) 604
rivaroxaban (601) 601
therapy (599) 599
aged, 80 and over (587) 587
tissue factor (582) 582
proteins (576) 576
rabbits (562) 562
disease models, animal (559) 559
platelet aggregation - drug effects (558) 558
prothrombin time (557) 557
blood coagulation tests (539) 539
hemorrhage (539) 539
atrial fibrillation (536) 536
factor xa inhibitors (535) 535
fibrinolysis (528) 528
biochemistry & molecular biology (523) 523
pharmacokinetics (521) 521
medical research (520) 520
blood platelets - drug effects (503) 503
drug therapy (501) 501
anticoagulation (499) 499
cardiology (492) 492
fibrinogen (487) 487
dabigatran etexilate (476) 476
management (469) 469
expression (467) 467
in-vitro (463) 463
inhibition (460) 460
hemorrhage - chemically induced (458) 458
prospective studies (449) 449
molecular-weight heparin (436) 436
blood platelets - metabolism (432) 432
rats, sprague-dawley (429) 429
thrombin - biosynthesis (424) 424
heparin - administration & dosage (422) 422
aspirin (419) 419
bleeding (415) 415
medicine, experimental (414) 414
cell biology (413) 413
thrombin time (410) 410
adolescent (409) 409
atrial-fibrillation (406) 406
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12519) 12519
German (193) 193
Russian (107) 107
French (59) 59
Japanese (50) 50
Spanish (26) 26
Chinese (18) 18
Italian (12) 12
Polish (12) 12
Dutch (7) 7
Portuguese (7) 7
Hungarian (4) 4
Czech (2) 2
Danish (2) 2
Norwegian (2) 2
Swedish (2) 2
Bulgarian (1) 1
Croatian (1) 1
Finnish (1) 1
Korean (1) 1
Lithuanian (1) 1
Serbian (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of thrombosis and haemostasis, ISSN 1538-7933, 2014, Volume 12, Issue 9, pp. 1428 - 1436
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 2014, Volume 12, Issue 10, pp. 1636 - 1646
Journal Article
by Schulman, Sam and Kakkar, Ajay K and Goldhaber, Samuel Z and Schellong, Sebastian and Eriksson, Henry and Mismetti, Patrick and Christiansen, Anita Vedel and Friedman, Jeffrey and Le Maulf, Florence and Peter, Nuala and Kearon, Clive and Schulman, S and Eriksson, H and Goldhaber, S and Kakkar, A and Kearon, C and Mismetti, P and Schellong, S and Bergqvist, D and Tijssen, J and Prins, M. [=Martin H.] and Robben, S and Büller, H and Otten, H. M and Brandjes, D and Peters, R and Mac Gillavry, M. R and Gan, E and Salem, H and Baker, R and Blomberry, P and Curnow, J and Annichino-Bizzacch, J. M and Brandao Panico, M. D and Timi Ribas, J. R and Fernandes Manenti, E. R and Miranda, F and Moraes, J and Raev, D and Mollov, M and Peneva, M and Milanov, S and Anderson, D and Crowther, M and Dolan, S and Eikelboom, J and Game, M and Kahn, S and Kassis, J and Ritchie, B and Solymoss, S and Rodger, M and Yeo, E and Milot, A and Klinke, P and Chen, W and Zhihong, L and Chunxue, B and Jinming, L and Jiwei, Z and Jie, C and Jina, K and Yuqi, W and Zhongqi, Y and Hua, W and Kejing, Y and Bonan, L and Yadong, Y and Changwei, L and Jin, Z and Yongcheng, D and Spinar, J and Maly, R and Cizek, V and Bercikova, J and Cervinka, P and Lang, P and Jirka, V and Oral, I and Reichert, P and Kotik, L and Pojsl, S and Klimovic, T and Husted, S and Nielsen, H and Friis, E and Skødebjerg Kristensen, K and Mottier, D and El Kouri, D and Bleher, Y and Leroux, L and Boda, Z and Sereg, M and Riba, M and Hiremath, J. S and Kareem, S and Banker, D. N and Gadkari, M and Parakh, R and Suresh, K. R and ... and RE-COVER II Trial Investigators
Circulation, ISSN 0009-7322, 2014, Volume 129, Issue 7, pp. 764 - 772
Dabigatran and warfarin have been compared for the treatment of acute venous thromboembolism (VTE) in a previous trial. We undertook this study to extend those... 
Antagonists & inhibitors | Recurrence | Thrombin | Warfarin | Hemorrhage | Venous thromboembolism | CARDIAC & CARDIOVASCULAR SYSTEMS | FONDAPARINUX | THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | RIVAROXABAN | INITIAL TREATMENT | PERIPHERAL VASCULAR DISEASE | ORAL ANTICOAGULANT-THERAPY | APIXABAN | UNFRACTIONATED HEPARIN | Anticoagulants - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Warfarin - adverse effects | Male | Antithrombins - administration & dosage | Dabigatran | Heparin - adverse effects | Warfarin - administration & dosage | Venous Thromboembolism - drug therapy | Young Adult | Benzimidazoles - administration & dosage | Adult | Female | Benzimidazoles - adverse effects | Venous Thromboembolism - epidemiology | beta-Alanine - analogs & derivatives | Acute Disease | beta-Alanine - adverse effects | Double-Blind Method | Hemorrhage - epidemiology | Risk Factors | beta-Alanine - administration & dosage | Anticoagulants - adverse effects | Antithrombins - adverse effects | Adolescent | Aged | Hemorrhage - chemically induced | Heparin, Low-Molecular-Weight - administration & dosage | Usage | Care and treatment | Dabigatran etexilate | Thromboembolism | Index Medicus | Abridged Index Medicus | Anticoagulants | Benzimidazoles | Heparin, Low-Molecular-Weight | Life Sciences | Venous Thromboembolism | Antithrombins | Heparin | beta-Alanine
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 04/2011, Volume 105, Issue 4, pp. 721 - 729
This trial compared the efficacy and safety of oral dabigatran, a direct thrombin inhibitor, versus subcutaneous enoxaparin for extended thromboprophylaxis in... 
Dabigatran etexilate | Oral anticoagulant | Total hip arthroplasty | Venous thromboembolism | Prophylaxis | SURGERY | DIRECT THROMBIN INHIBITOR | FONDAPARINUX | oral anticoagulant | PREVENTION | DEEP-VEIN THROMBOSIS | prophylaxis | total hip arthroplasty | KNEE REPLACEMENT | venous thromboembolism | MOLECULAR-WEIGHT HEPARIN | ETEXILATE | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Venous Thromboembolism - mortality | Anticoagulants - administration & dosage | Humans | Middle Aged | Male | Antithrombins - administration & dosage | Dabigatran | Enoxaparin - adverse effects | Venous Thromboembolism - prevention & control | Enoxaparin - administration & dosage | Benzimidazoles - administration & dosage | Hemorrhage - etiology | Injections, Subcutaneous | Female | Venous Thrombosis - prevention & control | Benzimidazoles - adverse effects | beta-Alanine - analogs & derivatives | Postoperative Complications | beta-Alanine - adverse effects | Double-Blind Method | Administration, Oral | Venous Thrombosis - mortality | beta-Alanine - administration & dosage | Anticoagulants - adverse effects | Venous Thrombosis - etiology | Venous Thromboembolism - etiology | Antithrombins - adverse effects | Survival Analysis | Arthroplasty, Replacement, Hip - mortality | Aged | Benzimidazoles | Venous Thrombosis | Oral | Hemorrhage | Antithrombins | Venous Thromboembolism | administration & dosage | Surgery | beta-Alanine | Administration | Anticoagulants | Subcutaneous | Enoxaparin | Arthroplasty | Replacement | prevention & control | Kirurgi | Hip | etiology | Injections | analogs & derivatives | adverse effects | mortality
Journal Article
ANESTHESIA AND ANALGESIA, ISSN 0003-2999, 10/2007, Volume 105, Issue 4, pp. 905 - 917
BACKGROUND: To explore whether disturbed fibrin polymerization is the main problem underlying dilutional coagulopathy and can be reversed by fibrinogen... 
CLOT FORMATION | PORCINE MODEL | IN-VITRO | DILUTIONAL COAGULOPATHY | BLOOD-COAGULATION | PLASMA COAGULATION KINETICS | FACTOR-XIII | ANESTHESIOLOGY | CARDIOPULMONARY BYPASS | THROMBIN-FIBRINOGEN | HEMODILUTION
Journal Article
British Journal of Surgery, ISSN 0007-1323, 06/2014, Volume 101, Issue 7, pp. 742 - 749
Journal Article
Archives of Pathology and Laboratory Medicine, ISSN 0003-9985, 05/2015, Volume 139, Issue 5, pp. 665 - 673
Journal Article
Circulation, ISSN 0009-7322, 11/2006, Volume 114, Issue 22, pp. 2374 - 2381
Background - Rivaroxaban (BAY 59-7939) -an oral, direct Factor Xa inhibitor-could be an alternative to heparins and warfarin for the prevention and treatment... 
Prevention | Anticoagulants | Thrombosis | Embolism | Coagulation | ENOXAPARIN | XIMELAGATRAN | CARDIAC & CARDIOVASCULAR SYSTEMS | DIRECT THROMBIN INHIBITOR | embolism | coagulation | POSTOPERATIVE FONDAPARINUX | thrombosis | KNEE REPLACEMENT | VENOUS THROMBOEMBOLISM | DABIGATRAN ETEXILATE | PHARMACOKINETICS | anticoagulants | PERIPHERAL VASCULAR DISEASE | II RANDOMIZED-TRIAL | prevention | Thiophenes - therapeutic use | Anticoagulants - administration & dosage | Double-Blind Method | Drug Administration Schedule | Factor Xa Inhibitors | Administration, Oral | Humans | Middle Aged | Morpholines - administration & dosage | Postoperative Complications - prevention & control | Anticoagulants - therapeutic use | Male | Hemorrhage - prevention & control | Thiophenes - administration & dosage | Rivaroxaban | Sample Size | Survival Analysis | Postmenopause | Adult | Arthroplasty, Replacement, Hip - mortality | Female | Safety | Morpholines - therapeutic use | Index Medicus | Abridged Index Medicus | Postoperative Complications/prevention & control | Administration | Anticoagulants/administration & dosage/therapeutic use | Morpholines/administration & dosage/therapeutic use | Arthroplasty | Replacement | Thiophenes/administration & dosage/therapeutic use | Oral | Kirurgi | Hemorrhage/prevention & control | Surgery | Hip/mortality | Factor Xa/antagonists & inhibitors
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 05/2017, Volume 253, pp. 122 - 136
Journal Article
Methods in Molecular Biology, ISSN 1064-3745, 2017, Volume 1646, pp. 217 - 225
Journal Article
Journal Article